Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early colchicine plus atorvastatin in statin-naive acute coronary syndrome
2021-000637-13Phase 2Completed
- Sponsor
- Azienda USL Toscana Centro
- Start
- Oct 2021
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of colchicine and atorvastatin in acute coronary syndrome (ACS) (2 arms), sponsored by Azienda USL Toscana Centro. Primary endpoint: Relative increase in hsCRP from baseline to discharge. Started Oct 2021; status: completed.
02
Drugs
colchicineatorvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2021-000637-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000637-13.